![Apo A. Sezginer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Apo A. Sezginer
Chief Tech/Sci/R&D Officer at Invarium, Inc.
Apo A. Sezginer active positions
Companies | Position | Start | End |
---|---|---|---|
Invarium, Inc.
![]() Invarium, Inc. Packaged SoftwareTechnology Services Invarium, Inc. provides patterning synthesis solutions. It provides best patterning solutions to customers engaged in design and manufacture of advanced integrated circuits to the semiconductor design and manufacturing industry. The company was founded in 2003 and is headquartered in San Jose, CA. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Apo A. Sezginer
Former positions of Apo A. Sezginer
Companies | Position | Start | End |
---|---|---|---|
SCHLUMBERGER LIMITED | Chief Tech/Sci/R&D Officer | - | - |
Sensys Medical Ltd.
![]() Sensys Medical Ltd. Medical DistributorsDistribution Services Since 1995, Sensys Medical, Inc. (f.k.a. Instrumentation Metrics) has been diligently working on the development of a non-invasive blood glucose analyzer to assist those individuals with diabetes control their blood sugar levels. The Company intends to commercialize its Glucose Tracking System (GTSâ'¢), which will dramatically advance the practice of blood glucose monitoring and the science of diabetes disease management. Sensys Medical continues to advance the technologies necessary to successfully develop a device that is accurate, precise and simple to use in the hands of individuals. Sensys Medical scientists and engineers have furthered the understanding of non-invasive blood glucose measurement with advancements in the disciplines of tissue optics, multivariate statistics, optical engineering and analysis, detector materials, finite element analysis and applied computational fluid dynamics. These advances are continually tested in clinical trials and refined to ensure that individuals are capable of obtaining accurate non-invasive blood glucose measurements with minimal effort from the subject. As results from these trials become available, they will be shared through presentations and/or publications. | Chief Tech/Sci/R&D Officer | - | - |
Training of Apo A. Sezginer
Massachusetts Institute of Technology | Undergraduate Degree |
Statistics
International
United States | 4 |
United Kingdom | 2 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Sectoral
Technology Services | 2 |
Finance | 2 |
Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SCHLUMBERGER LIMITED | Industrial Services |
Private companies | 2 |
---|---|
Invarium, Inc.
![]() Invarium, Inc. Packaged SoftwareTechnology Services Invarium, Inc. provides patterning synthesis solutions. It provides best patterning solutions to customers engaged in design and manufacture of advanced integrated circuits to the semiconductor design and manufacturing industry. The company was founded in 2003 and is headquartered in San Jose, CA. | Technology Services |
Sensys Medical Ltd.
![]() Sensys Medical Ltd. Medical DistributorsDistribution Services Since 1995, Sensys Medical, Inc. (f.k.a. Instrumentation Metrics) has been diligently working on the development of a non-invasive blood glucose analyzer to assist those individuals with diabetes control their blood sugar levels. The Company intends to commercialize its Glucose Tracking System (GTSâ'¢), which will dramatically advance the practice of blood glucose monitoring and the science of diabetes disease management. Sensys Medical continues to advance the technologies necessary to successfully develop a device that is accurate, precise and simple to use in the hands of individuals. Sensys Medical scientists and engineers have furthered the understanding of non-invasive blood glucose measurement with advancements in the disciplines of tissue optics, multivariate statistics, optical engineering and analysis, detector materials, finite element analysis and applied computational fluid dynamics. These advances are continually tested in clinical trials and refined to ensure that individuals are capable of obtaining accurate non-invasive blood glucose measurements with minimal effort from the subject. As results from these trials become available, they will be shared through presentations and/or publications. | Distribution Services |
- Stock Market
- Insiders
- Apo A. Sezginer
- Experience